Breast CancerClinical TopicsNewsOncologyOncology Resource CenterPublic Health

Study examines rate of cancer overdiagnosis in Australia

Share
By: Lydia L. Kim, Digital Content Editor

A recent study published in the Medical Journal of Australia examined the “proportion of cancer diagnoses in Australia that might reasonably be attributed to overdiagnosis.”

The research team collected data between 1982 and 2012 from the Australian Institute of Health and Welfare and analyzed five different cancer types: breast, prostate, renal, thyroid, and melanoma. The outcomes were measured by the “difference in lifetime risks of cancer diagnosis between 1982 and 2012.”

Ultimately, the data revealed that annually, roughly 11,000 of cancer cases in women and 18,000 in men may be overdiagnosed. The researchers suggest that healthcare providers and services in Australia should  “monitor emerging areas of overdiagnosis” as these rates may need to be reduced.

Please read more about the study here.

Source:
https://www.mja.com.au/journal/2020/212/4/estimating-magnitude-cancer-overdiagnosis-australia?utm_source=carousel&utm_medium=web&utm_campaign=homepage

*Online Bonus Content: This has not been peer reviewed. The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal.

Take the 2024 Nursing Trends and Salary Survey, available now through November 1st 2024

See Past Results
cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

What is the primary purpose of a 3-minute foot assessment in patients with comorbidities such as diabetes or peripheral arterial disease?

More News